Walgreens Boots Alliance is set to release its earnings report for the fiscal first quarter on Thursday before the market opens. Here's a breakdown of what you need to know:

Net Income

According to FactSet, analysts are expecting Walgreens to swing to a net profit of $367.6 million, or 24 cents per share. This is a significant improvement compared to the losses of $3.72 billion, or $4.31 per share, reported in the same period last year, primarily due to opioid-related settlements.

Adjusted Earnings Per Share

When excluding one-time items, the drugstore chain's forecasted earnings per share are expected to be 53 cents, as reported by FactSet.


FactSet predicts that Walgreens' sales will rise to $34.95 billion for the quarter, compared to $33.38 billion in the same period last year.

During the quarter, the company's stock rose by 15% and is currently trading at $25.81.

Key Areas of Interest

  • New Finance Chief: Investors will be keen to hear about any updates on the identification of a new finance chief to replace James Kehoe, who departed in August to join fintech company FIS Global.

  • Business Performance of Boots: Following a Bloomberg report suggesting that Walgreens is considering an exit from the U.K. pharmacy chain Boots, investors will closely monitor any comments regarding the business performance and future plans for Boots.

  • Healthcare Business Expansion: The market will be interested in Walgreens' plans for expanding its healthcare business and addressing the ongoing pharmacist shortage.

  • Covid-19 Impact: Any commentary on the company's Covid-19-related sales will also be of significant interest to investors.

Post a comment